Eco Animal Health Group PLC EAH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EAH is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- GBX 112.50
- Day Range
- GBX 110.00–114.13
- 52-Week Range
- GBX 82.67–125.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 7.62 Bil
- Volume/Avg
- 25,212 / 157,947
Key Statistics
- Price/Earnings (Normalized)
- 178.86
- Price/Sales
- 0.87
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The geographical segments of the company include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 228
Comparables
Valuation
|
Metric
|
EAH
|
AVCT
|
OFSA3
|
|---|---|---|---|
Price/Earnings (Normalized) | 178.86 | — | 22.78 |
Price/Book Value | 0.93 | 5.92 | 1.69 |
Price/Sales | 0.87 | 5.34 | 1.22 |
Price/Cash Flow | 17.04 | — | 20.92 |
Price/Earnings
EAH
AVCT
OFSA3
Financial Strength
|
Metric
|
EAH
|
AVCT
|
OFSA3
|
|---|---|---|---|
Quick Ratio | 2.25 | 0.66 | 2.64 |
Current Ratio | 3.16 | 0.71 | 3.56 |
Interest Coverage | 1.93 | −3.70 | 2.41 |
Quick Ratio
EAH
AVCT
OFSA3
Profitability
|
Metric
|
EAH
|
AVCT
|
OFSA3
|
|---|---|---|---|
Return on Assets (Normalized) | 1.86% | −39.45% | 3.88% |
Return on Equity (Normalized) | 2.63% | −115.60% | 7.31% |
Return on Invested Capital (Normalized) | 2.70% | −49.08% | 6.76% |
Return on Assets
EAH
AVCT
OFSA3
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Kwrwvnyrjt | Jxqxm | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Lkjqctpndt | Hwsgwcv | $70.9 Bil | |
HLN
| Haleon PLC ADR | Xgpztfk | Cnshc | $37.8 Bil | |
VTRS
| Viatris Inc | Dhjthdsq | Hgty | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hkwppgd | Xdzm | $12.7 Bil | |
CTLT
| Catalent Inc | Qwfdlyy | Bsktzz | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Gtbvdsgrl | Gzp | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Bpmbdfh | Ppx | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ylrrpns | Dqkgnb | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Tvyhxfmnst | Bxwz | $3.1 Bil |